BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25511139)

  • 1. Cytogenetic and flow cytometry evaluation of Richter syndrome reveals MYC, CDKN2A, IGH alterations with loss of CD52, CD62L and increase of CD71 antigen expression as the most frequent recurrent abnormalities.
    Woroniecka R; Rymkiewicz G; Grygalewicz B; Błachnio K; Rygier J; Jarmuż-Szymczak M; Ratajczak B; Pieńkowska-Grela B
    Am J Clin Pathol; 2015 Jan; 143(1):25-35. PubMed ID: 25511139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Richter transformation with c-MYC overexpression: report of three cases.
    Wang L; Aghel A; Peterson B; Wang-Rodriguez J; Wang HY; Zhao XF
    Int J Clin Exp Pathol; 2015; 8(6):7540-6. PubMed ID: 26261666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual cancer lymphocytes in patients with chronic lymphocytic leukemia after therapy show increased expression of surface antigen CD52 detected using quantitative fluorescence cytometry.
    Pevna M; Doubek M; Coupek P; Stehlikova O; Klabusay M
    Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):411-8. PubMed ID: 25066039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.
    Lu G; Kong Y; Yue C
    Cancer Genet Cytogenet; 2010 Jan; 196(1):56-63. PubMed ID: 19963136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia.
    Cobo F; Martínez A; Pinyol M; Hernández L; Gómez M; Beá S; Esteve J; Rozman M; Bosch F; López-Guillermo A; Montserrat E; Campo E
    Leukemia; 2002 Jun; 16(6):1028-34. PubMed ID: 12040434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.
    Rossi D; Spina V; Cerri M; Rasi S; Deambrogi C; De Paoli L; Laurenti L; Maffei R; Forconi F; Bertoni F; Zucca E; Agostinelli C; Cabras A; Lucioni M; Martini M; Magni M; Deaglio S; Ladetto M; Nomdedeu JF; Besson C; Ramponi A; Canzonieri V; Paulli M; Marasca R; Larocca LM; Carbone A; Pileri SA; Gattei V; Gaidano G
    Clin Cancer Res; 2009 Jul; 15(13):4415-22. PubMed ID: 19509140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
    Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
    J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome).
    Beà S; López-Guillermo A; Ribas M; Puig X; Pinyol M; Carrió A; Zamora L; Soler F; Bosch F; Stilgenbauer S; Colomer D; Miró R; Montserrat E; Campo E
    Am J Pathol; 2002 Sep; 161(3):957-68. PubMed ID: 12213724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic abnormalities detected by fluorescence in situ hybridization on paraffin-embedded chronic lymphocytic leukemia/small lymphocytic lymphoma lymphoid tissue biopsy specimens.
    Flanagan MB; Sathanoori M; Surti U; Soma L; Swerdlow SH
    Am J Clin Pathol; 2008 Oct; 130(4):620-7. PubMed ID: 18794056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis.
    Travella A; Ripollés L; Aventin A; Rodríguez A; Bezares RF; Caballín MR; Slavutsky I
    Hematol Oncol; 2013 Jun; 31(2):79-87. PubMed ID: 22961973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lymphocytic leukemia FISH panel: impact on diagnosis.
    Nelson BP; Gupta R; Dewald GW; Paternoster SF; Rosen ST; Peterson LC
    Am J Clin Pathol; 2007 Aug; 128(2):323-32. PubMed ID: 17638669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism.
    Mone AP; Cheney C; Banks AL; Tridandapani S; Mehter N; Guster S; Lin T; Eisenbeis CF; Young DC; Byrd JC
    Leukemia; 2006 Feb; 20(2):272-9. PubMed ID: 16341049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of IgVH gene somatic hypermutation and interphase cytogenetics in lymphomatous presentation of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Yeung CC; Powers ML; Nguyen TD; Kreisel F; Frater JL; Zehnbauer BA; Burack R; Hassan A
    Int J Surg Pathol; 2011 Oct; 19(5):563-9. PubMed ID: 21536543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
    Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Richter syndrome: biology, incidence, and therapeutic strategies.
    Tsimberidou AM; Keating MJ
    Cancer; 2005 Jan; 103(2):216-28. PubMed ID: 15578683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomorphologic spectrum of small lymphocytic lymphoma in patients with an accelerated clinical course.
    Shin HJ; Caraway NP; Katz RL
    Cancer; 2003 Oct; 99(5):293-300. PubMed ID: 14579296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia.
    Smilevska T; Stamatopoulos K; Samara M; Belessi C; Tsompanakou A; Paterakis G; Stavroyianni N; Athanasiadou I; Chiotoglou I; Hadzidimitriou A; Athanasiadou A; Douka V; Saloum R; Laoutaris N; Anagnostopoulos A; Fassas A; Stathakis N; Kollia P
    Leuk Res; 2006 Feb; 30(2):183-9. PubMed ID: 16054692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in Shanghai, China: molecular and cytogenetic characteristics, IgV gene restriction and hypermutation patterns.
    Irons RD; Le A; Bao L; Zhu X; Ryder J; Wang XQ; Ji M; Chen Y; Wu X; Lin G
    Leuk Res; 2009 Dec; 33(12):1599-603. PubMed ID: 19428103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.